RxDoctor Payments Data

Emily Sombke, PA

Physician Assistant · Huntington, NYNPI 1770980534

Payments from drug & device makers

$1,720in general payments, 2019–2025

Across 84 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$499
  • AstraZeneca$296
  • Exact Sciences$251
  • Novartis$146
  • Amgen$94
  • Daiichi Sankyo Inc.$71
  • plus $364 from 12 others

What the payments were for

  • Food & beverage$1,720100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,720 in reported general payments places this provider in the 80th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$40,168
Medicare patients
267
Services billed
480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$19,814
JardianceEmpagliflozin13$14,063
Levothyroxine Sodium94$1,091
Atorvastatin Calcium121$1,019
Rosuvastatin Calcium59$935
Metoprolol Succinate50$811
Albuterol Sulfate HfaAlbuterol Sulfate20$661
Valsartan23$645
Amlodipine Besylate104$618
Famotidine39$612
Gabapentin44$569
Metformin Hcl ErMetformin Hcl46$442
Fluticasone Propionate50$430
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide14$410
Pantoprazole Sodium34$400

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$69$19,81417 claims
Boehringer IngelheimJardiance$60$14,06313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Huntington

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →